China (Mainland)
Rivaroxaban CAS NO.366789-02-8
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Rivaroxaban Manufacturer
- (S)-Rivaroxaban
- Supply Rivaroxaban
Quick Details
- ProName: Rivaroxaban
- CasNo: 366789-02-8
- Molecular Formula: C19H18ClN3O5S
- Appearance: White powder
- Application: Used as an anticholelithogenic.
- DeliveryTime: For stock products could be ship out w...
- PackAge: 1KG/Bag or Bottle,25KG per Box or Drum...
- Port: Shanghai ,Ningbo ,Qingdao ,Tianjin etc...
- ProductionCapacity: 10 Metric Ton/Quarter
- Purity: As COA
- Storage: Keep sealed when not in use .
- Transportation: By DHL /Fedex /TNT /EMS /Air /Sea etc.
- LimitNum: 1 Gram
Superiority
Shanghai Siwei Chemical Co., Ltd is located in Shanghai,China .Our main business is Pharmaceutical Intermediates ,OLED Intermediates ,Food Additives ,Nano Materials ,Rare Earth Materials etc.
We have professional customer service 24H online answer your questions .Cheap price with best quality is our
Have long-term and stable cooperation with major factories and unicersities can provide the best quality with cheap price .
Welcome your inquires ,we are always on your side .
Details
Rivaroxaban Basic information
Product Name: Rivaroxaban
Synonyms: (S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939;Rivaroxaban Isomer;Rivaroxaban;5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
CAS: 366789-02-8
MF: C19H18ClN3O5S
MW: 435.88
EINECS: 685-132-2
Rivaroxaban Chemical Properties
Melting point 228-229°C
Boiling point 732.6±60.0 °C(Predicted)
density 1.460±0.06 g/cm3(Predicted)
storage temp. Refrigerator
pka 13.36±0.46(Predicted)
Rivaroxaban Usage And Synthesis
Uses Rivaroxaban is recommended as an option for treating pulmonary embolism and preventing recurrent deep vein thrombosis and pulmonary embolism in adults.
Rivaroxaban (Xarelto, Bayer) is indicated for the 'treatment of deep vein thrombosis and pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults'. For the initial treatment of acute pulmonary embolism, the recommended dosage of rivaroxaban is 15 mg twice daily for the first 21 days followed by 20 mg once daily for continued treatment and prevention of recurrent venous thromboembolism.
Non-Valvular Atrial Fibrillation (NVAF)* to prevent stroke & systemic embolism.
Acute VTE treatment & prevention of recurrent VTE [for deep vein thrombosis (DVT) and pulmonary embolism (PE)].
Prevention of venous thromboembolic events (VTE) in elective total hip or knee replacement surgery (THR, TKR).